Market Overview:
The global LVAD market is expected to grow at a CAGR of 10.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of heart failure, technological advancements in LVAD devices, and rising number of approvals for LVAD devices by regulatory authorities. The global LVAD market is segmented on the basis of type into BTT therapy, BTD therapy, destination therapy, and BTR therapy. The BTT therapy segment is expected to account for the largest share of the global LVAD market in 2018 owing to its growing popularity among patients with heart failure. By application, hospitals are expected to account for the largest share of the global LVAD market in 2018 followed by ambulatory surgical centers (ASCs).
Product Definition:
LVAD is an abbreviation for left ventricular assist device. It is a medical device that helps pump blood from the left ventricle of the heart to the rest of the body. LVADs are often used as a bridge to transplant, meaning they help keep someone alive until they can receive a new heart.
BTT Therapy:
BTT therapy, also known as blood transfusion therapy is used to treat patients with low blood volume and/or low blood pressure. It involves the infusion of a patient’s or donors’ own blood into the circulatory system of a patient who has suffered from severe bleeding. BTT is most commonly used in cases where there are no suitable alternatives such as coagulation factor concentrates or fresh frozen plasma.
BTD Therapy:
BTD therapy is a combination of two drugs, Baycol (dextromethorphan/quinidine) and Nuedexta (dextromethorphan/quinidine). It has been used in the treatment of heart failure with reduced ejection fraction. BTD reduces the symptoms and signs of congestive heart failure by improving cardiac function.
Application Insights:
Based on application, the global LVAD market is segmented into hospitals and ambulatory surgical centers. The hospital segment dominated the overall market in terms of revenue in 2017 owing to a high prevalence of cardiovascular diseases that require long-term care and a large number of heart transplant surgeries every year. In addition, an increasing number of patients suffering from end-stage heart failure are undergoing dialysis or having kidney transplants, which further drives demand for long-term cardiac care and supportive therapy which includes LVADs.
The ambulatory surgical center (ASC) segment is expected to grow at the fastest rate during the forecast period due to rising awareness about ASCs among patients with nonurgent medical conditions such as diabetes mellitus type 2 or chronic renal failure requiring a longer stay in hospital than anticipated. Furthermore, growing initiatives by private healthcare providers for setting up permanent facilities at convenient locations near patient homes will boost growth further over the forecast period.
Regional Analysis:
North America dominated the global LVAD market in 2017. This can be attributed to the presence of a large number of patients suffering from heart failure, increasing healthcare expenditure and technological advancements in cardiac care. Moreover, growing awareness about advanced technologies for treating heart failure is also expected to drive growth during the forecast period.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to factors such as improving healthcare infrastructure and rising patient awareness about emerging therapies for treating heart failure. Furthermore, an increase in government initiatives aimed at improving treatment options for patients suffering from cardiac disorders is further anticipated to boost demand during the projected time frame. For instance, The Government of India has launched “Swachhata Hi Seva†(Cleanliness drives) scheme with an aim towards creating healthy environments free from filth that would ultimately lead towards improved health outcomes among people affected with cardiovascular diseases such as stroke or coronary artery disease (CAD).
Growth Factors:
- Increasing prevalence of heart failure: The global prevalence of heart failure is expected to increase from 26 million in 2010 to over 40 million by 2030. This will create a large pool of patients who could potentially benefit from LVAD therapy.
- Advances in technology and device design: LVAD technology is constantly evolving, with new devices becoming smaller, more efficient and easier to implant. This will help make LVAD therapy more accessible to a wider range of patients.
- Growing awareness and acceptance of LVAD therapy: There is growing awareness and acceptance of LVAD therapy among both physicians and patients alike. This is helping to drive adoption rates for the treatment modality worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
LVAD Market Research Report
By Type
BTT Therapy, BTD Therapy, Destination Therapy, BTR Therapy
By Application
Hospitals, Ambulatory Surgical Centers
By Companies
Abiomed, Berlin Heart, HeartWare International, Jarvik Heart, Abbott, Cardiac Assist, Evaheart, ReliantHeart, Sun Medical Technology Research, Sunshine Heart, Abiomed
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
206
Number of Tables & Figures
145
Customization Available
Yes, the report can be customized as per your need.
Global LVAD Market Report Segments:
The global LVAD market is segmented on the basis of:
Types
BTT Therapy, BTD Therapy, Destination Therapy, BTR Therapy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abiomed
- Berlin Heart
- HeartWare International
- Jarvik Heart
- Abbott
- Cardiac Assist
- Evaheart
- ReliantHeart
- Sun Medical Technology Research
- Sunshine Heart
- Abiomed
Highlights of The LVAD Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- BTT Therapy
- BTD Therapy
- Destination Therapy
- BTR Therapy
- By Application:
- Hospitals
- Ambulatory Surgical Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the LVAD Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
LVAD stands for left ventricular assist device. It is a mechanical device that helps the heart pump blood. LVADs are used in people who have heart failure and cannot get enough oxygen to their cells because of a problem with their lungs or heart.
Some of the major players in the lvad market are Abiomed, Berlin Heart, HeartWare International, Jarvik Heart, Abbott, Cardiac Assist, Evaheart, ReliantHeart, Sun Medical Technology Research, Sunshine Heart, Abiomed.
The lvad market is expected to grow at a compound annual growth rate of 10.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 LVAD Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 LVAD Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 LVAD Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the LVAD Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global LVAD Market Size & Forecast, 2018-2028 4.5.1 LVAD Market Size and Y-o-Y Growth 4.5.2 LVAD Market Absolute $ Opportunity
Chapter 5 Global LVAD Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 LVAD Market Size Forecast by Type
5.2.1 BTT Therapy
5.2.2 BTD Therapy
5.2.3 Destination Therapy
5.2.4 BTR Therapy
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global LVAD Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 LVAD Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global LVAD Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 LVAD Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America LVAD Analysis and Forecast
9.1 Introduction
9.2 North America LVAD Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America LVAD Market Size Forecast by Type
9.6.1 BTT Therapy
9.6.2 BTD Therapy
9.6.3 Destination Therapy
9.6.4 BTR Therapy
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America LVAD Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgical Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe LVAD Analysis and Forecast
10.1 Introduction
10.2 Europe LVAD Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe LVAD Market Size Forecast by Type
10.6.1 BTT Therapy
10.6.2 BTD Therapy
10.6.3 Destination Therapy
10.6.4 BTR Therapy
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe LVAD Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgical Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific LVAD Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific LVAD Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific LVAD Market Size Forecast by Type
11.6.1 BTT Therapy
11.6.2 BTD Therapy
11.6.3 Destination Therapy
11.6.4 BTR Therapy
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific LVAD Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgical Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America LVAD Analysis and Forecast
12.1 Introduction
12.2 Latin America LVAD Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America LVAD Market Size Forecast by Type
12.6.1 BTT Therapy
12.6.2 BTD Therapy
12.6.3 Destination Therapy
12.6.4 BTR Therapy
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America LVAD Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgical Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) LVAD Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) LVAD Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) LVAD Market Size Forecast by Type
13.6.1 BTT Therapy
13.6.2 BTD Therapy
13.6.3 Destination Therapy
13.6.4 BTR Therapy
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) LVAD Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgical Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 LVAD Market: Competitive Dashboard
14.2 Global LVAD Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abiomed
14.3.2 Berlin Heart
14.3.3 HeartWare International
14.3.4 Jarvik Heart
14.3.5 Abbott
14.3.6 Cardiac Assist
14.3.7 Evaheart
14.3.8 ReliantHeart
14.3.9 Sun Medical Technology Research
14.3.10 Sunshine Heart
14.3.11 Abiomed